Abstract

Cytokine-inducible nitric-oxide (NO) synthase (iNOS) contains an oxygenase domain that binds heme, tetrahydrobiopterin, and L-arginine, and a reductase domain that binds FAD, FMN, calmodulin, and NADPH. Dimerization of two oxygenase domains allows electrons to transfer from the flavins to the heme irons, which enables O2 binding and NO synthesis from L-arginine. In an iNOS heterodimer comprised of one full-length subunit and an oxygenase domain partner, the single reductase domain transfers electrons to only one of two hemes (Siddhanta, U., Wu, C., Abu-Soud, H. M., Zhang, J., Ghosh, D. K., and Stuehr, D. J. (1996) J. Biol. Chem. 271, 7309-7312). Here, we characterize a pair of heterodimers that contain an L-Arg binding mutation (E371A) in either the full-length or oxygenase domain subunit to identify which heme iron becomes reduced. The E371A mutation prevented L-Arg binding to one oxygenase domain in each heterodimer but did not affect the L-Arg affinity of its oxygenase domain partner and did not prevent heme iron reduction in any case. The mutation prevented NO synthesis when it was located in the oxygenase domain of the adjacent subunit but had no effect when in the oxygenase domain in the same subunit as the reductase domain. Resonance Raman characterization of the heme-L-Arg interaction confirmed that E371A only prevents L-Arg binding in the mutated oxygenase domain. Thus, flavin-to-heme electron transfer proceeds exclusively between adjacent subunits in the heterodimer. This implies that domain swapping occurs in an iNOS dimer to properly align reductase and oxygenase domains for NO synthesis.

Highlights

  • Cytokine-inducible nitric-oxide (NO) synthase contains an oxygenase domain that binds heme, tetrahydrobiopterin, and L-arginine, and a reductase domain that binds FAD, FMN, calmodulin, and NADPH

  • The single reductase domain of this “wild-type” heterodimer transferred NADPH-derived electrons to only one of the two heme irons located in the dimeric oxygenase core, but OXYWT, a heterodimer comprised of a full-length inducible nitric-oxide (NO) synthase (iNOS) subunit containing the E371A mutation and a wild-type oxygenase domain subunit; FLWT/OXYE371A, a heterodimer comprised of a full-length wild-type iNOS subunit and an oxygenase domain subunit containing the E371A mutation; FLWT/OXYWT, a heterodimer comprised of wild-type fulllength and oxygenase domain subunits

  • This was sufficient to support a normal rate of NO synthesis by that heme [29]. These results showed that dimerization enables the flavin-to-heme electron transfer, they did not identify which of the two hemes accepts electrons from the single reductase domain and did not distinguish whether electron transfer occurs between flavin and heme groups located in the same or adjacent subunits of a dimer

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Chemicals, culture media, and chromatography resins were obtained from sources previously reported [22, 23, 29, 30]. 54Fe metal wire was from Cambridge Isotope Laboratories, Cambridge, MA. Proteins were purified as described previously [22, 23] using Ni2ϩ-chelate affinity resin equilibrated with 40 mM EPPS, pH 7.6, containing 0.25 M NaCl, 4 ␮M H4B, and 1 mM L-Arg. After initial adsorption the column was washed with equilibration buffer followed by the same buffer containing 60 mM imidazole. The iNOS (10 –50 nM with respect to heme iron concentration) was added to a cuvette containing 40 mM EPPS, pH 7.6, supplemented with 10% glycerol, 0.3 mM DTT, 5 mM L-Arg, 4 ␮M each of FAD, FMN, and H4B, 100 units/ml catalase, 10 units/ml superoxide dismutase, 0.1 mg/ml bovine serum albumin, and 10 ␮M oxyhemoglobin to give a final volume of 0.3 ml. An anaerobic solution of L-Arg was added to give a final concentration of 3 mM

RESULTS
92 Ϯ 10 69 Ϯ 1
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.